Brief: Chiome To Grant Co Exclusive Right And License To Antibodies Targeting Human Trop2

Chiome Bioscience

14/01/2021 12:52

Jan 14 (Reuters) - Shanghai Henlius Biotech Inc  2696.HK :
    * CHIOME TO GRANT CO EXCLUSIVE RIGHT AND LICENSE TO
ANTIBODIES
TARGETING HUMAN TROP2 AND RELATED IP RIGHTS
    * UNDER DEAL, CO WILL PAY CHIOME AN INITIAL PAYMENT OF US$1
MILLION
    * CO WILL PAY CHIOME DEVELOPMENT MILESTONE PAYMENTS OF NO
MORE
THAN US$23.0 MILLION

Source text for Eikon:  ID:nHKS9SzjmH 
Further company coverage:  2696.HK 

 ((Reuters.Briefs@thomsonreuters.com;))